VITRAKVI® is an oral medicine that is not a chemotherapy
- VITRAKVI is the first medicine specifically designed to block TRK proteins
- VITRAKVI is thought to work by blocking these proteins and stopping cancer cells from growing, but the exact way VITRAKVI works is unknown
- VITRAKVI can work in a variety of tumor types as long as the tumor is caused by an NTRK gene fusion
Are you and your doctor considering treatment with VITRAKVI?
Before you can take VITRAKVI, your healthcare provider will perform a test to make sure that VITRAKVI is right for you.
VITRAKVI Voices: Your story can inspire others
If you are a patient currently taking VITRAKVI or are a caregiver, we would love to hear about your personal experience.